A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March 2013 issue of Nature by Prof Dimmler, Boon, and others.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Myocardial Infarction: Curcumin, the major component of turmeric, improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10). This study suggests, for the first time, that Curcumin, by increasing the expression of PNUTS/PPP1R10, it may: (1) inhibit DNA damage responses, (2) inhibit telomere shortening; and (3) promote cardimyocyte survival. Therefore, by consuming low doses of Garlic, one may protect himself/herself from ageing-associated decline in cardiac function. Together, pharmacological formulations encompassing “Curcumin or its analogues” may be used to improve cardiac function after myocardial infarction. Based on this interesting finding, Physicians may consider encouraging their cardiac patients to consume limited amount of Curcumin, to protect themselves from heart diseases.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Natural product-based therapy for Myocardial Infarction: Curcumin improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 26/February/2015, 17.16, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
Amount: $500*
Undisclosed information: How Curcumin increases the expression of PNUTS/PPP1R10